Midday Report: Cue (CUE) Trades Higher June 23

Equities Staff  |

Cue Biopharma Inc (NASDAQ: CUE) shares are up 5.23%, or $0.16 per share, as on 11:53:11 est today. Since opening the day at $3.09, 181,864 shares of Cue have exchanged hands and the stock has moved between $3.29 and $3.09.  

Already the company has moved YTD 72.94%.

Cue expects its next earnings on 2022-08-09.

For technical charts, analysis, and more on Cue visit the company profile.

About Cue Biopharma Inc

Cue Biopharma, a clinical-stage biopharmaceutical company, is engineering a novel class of injectable biologics to selectively engage and modulate targeted T cells directly within the patient's body to transform the treatment of cancer, infectious diseases and autoimmune diseases. The company's proprietary platform, Immuno-STAT ™(Selective Targeting and Alteration of T cells) is designed to harness the body's intrinsic immune system without the need for ex vivo manipulation.

To get more information on Cue Biopharma Inc and to follow the company's latest updates, you can visit the company's profile page here: Cue Biopharma Inc's Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Trending Articles

Investors Must Understand 5G Wireless Growth Wave: Jeff Kagan
'Goldilocks' Stocks Will Define This Decade
What You Need To Know About Bear Markets
Is Your iPhone Already Obsolete?



Market Movers

Sponsored Financial Content